Green Cross Cell Corporation is a biotechnology company that specializes in cell therapy and contract development and manufacturing organization (CDMO) services. The company operates within the biotechnology industry and claims to have the largest capacity for cell therapeutic manufacturing in Asia. It provides solutions for cellular genetic therapies, including logistics and storage services. The target market includes domestic and international patients in need of advanced cell therapies. Green Cross Cell employs a national bio network for manufacturing and distribution, offering services from research to commercialization. One of its key products is the CBNK (Cord blood-derived NK) therapy, which is a non-engineered, cryopreserved allogeneic drug.
Headquarters
107, Ihyeon-ro 30beon-gil Giheung-gu Yongin-si Gyeonggi
Yongin; Gyeonggi;
Postal Code: 153769
Contact Details: Purchase the Green Cross Cell Corporation report to view the information.
Website: http://www.greencrosscell.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service